Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).

Authors: Versleijen-Jonkers, Yvonne M. H., Hillebrandt-Roeffen, Melissa H. S., Weidema, Marije E., Mooren, Jeroen, von Rhein, Daniel T., de Bitter, Tessa J. J., Kroeze, Leonie I., Desar, Ingrid M. E., Flucke, Uta E.

Source: Scientific Reports; 2/14/2023, Vol. 13 Issue 1, p1-7, 7p

Subject Terms: NUCLEOTIDE sequencing, ANGIOSARCOMA, BREAST, ULTRAVIOLET radiation, RADIOTHERAPY safety, DOSE-response relationship (Radiation), DNA damage, CELL lines

Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.

Authors: van Ravensteijn, Stefan G., Versleijen-Jonkers, Yvonne M. H., Hillebrandt-Roeffen, Melissa H. S., Weidema, Marije E., Nederkoorn, Maikel J. L., Bol, Kalijn F., Gorris, Mark A. J., Verrijp, Kiek, Kroeze, Leonie I., de Bitter, Tessa J. J., de Voer, Richarda M., Flucke, Uta E., Desar, Ingrid M. E.

Source: Cancers; Dec2022, Vol. 14 Issue 23, p5938, 14p

Subject Terms: BIOMARKERS, IMMUNOCHEMISTRY, GENETICS, GENETIC mutation, B cell lymphoma, REGULATORY T cells, GENOMICS, CELL lines, SARCOMA, IMMUNOTHERAPY, RARE diseases, T-cell lymphoma

Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.

Authors: de Bitter, Tessa J. J., de Reuver, Philip R., de Savornin Lohman, Elise A. J., Kroeze, Leonie I., Vink-Börger, Marianne E., van Vliet, Shannon, Simmer, Femke, von Rhein, Daniel, Jansen, Erik A. M., Verheij, Joanne, van Herpen, Carla M. L., Nagtegaal, Iris D., Ligtenberg, Marjolijn J. L., van der Post, Rachel S.

Source: NPJ Precision Oncology; 11/5/2022, Vol. 6 Issue 1, p1-9, 9p

Subject Terms: GALLBLADDER cancer, GENE amplification, CLINICAL pathology, SURVIVAL rate, GENETIC mutation

Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020.

Authors: Kooijman, Jeffrey J., van Riel, Wilhelmina E., Dylus, Jelle, Prinsen, Martine B. W., Grobben, Yvonne, de Bitter, Tessa J. J., van Doornmalen, Antoon M., Melis, Janneke J. T. M., Uitdehaag, Joost C. M., Yugo Narumi, Yusuke Kawase, de Roos, Jeroen A. D. M., Willemsen-Seegers, Nicole, Zaman, Guido J. R.

Source: Frontiers in Oncology; 9/14/2022, Vol. 12, p1-22, 22p

Subject Terms: KINASE inhibitors, CANCER cells, CELL lines, CLINICAL indications, CELL survival

Company/Entity: UNITED States. Food & Drug Administration

Metastasis in the gallbladder: does literature reflect reality?

Authors: de Bitter, Tessa J. J., Trapman, Daan M., Simmer, Femke, Hugen, Niek, de Savornin Lohman, Elise A. J., de Reuver, Philip R., Verheij, Joanne, Nagtegaal, Iris D., van der Post, Rachel S.

Source: Virchows Archiv: European Journal of Pathology; Jun2022, Vol. 480 Issue 6, p1201-1209, 9p

Unraveling Neuroendocrine Gallbladder Cancer: Comprehensive Clinicopathologic and Molecular Characterization.

Authors: de Bitter, Tessa J. J.¹ (AUTHOR) Tessa.JJ.deBitter@radboudumc.nl, Kroeze, Leonie I.¹ (AUTHOR), de Reuver, Philip R.² (AUTHOR), van Vliet, Shannon¹ (AUTHOR), Vink-Börger, Elisa¹ (AUTHOR), von Rhein, Daniel³ (AUTHOR), Jansen, Erik A. M.³ (AUTHOR), Nagtegaal, Iris D.¹ (AUTHOR), Ligtenberg, Marjolijn J. L.^1,3 (AUTHOR), van der Post, Rachel S.¹ (AUTHOR)

Source: JCO Precision Oncology. 5/10/2021, Vol. 5, p473-484. 12p.

Subject Terms: *MERKEL cell carcinoma, *GALLBLADDER cancer, *PRECANCEROUS conditions, *GENE fusion, *TUMORS, *DIAGNOSIS, *CARCINOMA

Geographic Terms: NETHERLANDS

Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease.

Authors: de Savornin Lohman, Elise A. J., van der Geest, Lydia G., de Bitter, Tessa J. J., Nagtegaal, Iris D., van Laarhoven, Cornelis J. H. M., van den Boezem, Peter, van der Post, Chella S., de Reuver, Philip R.

Source: Annals of Surgical Oncology: An Oncology Journal for Surgeons; Apr2020, Vol. 27 Issue 4, p1132-1142, 11p

Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications.

Authors: Kuipers, Hendrien¹ (AUTHOR) h.kuipers01@umcg.nl, de Bitter, Tessa J. J.² (AUTHOR) tessa.jj.debitter@radboudumc.nl, de Boer, Marieke T.¹ (AUTHOR) m.w.nijkamp@umcg.nl, van der Post, Rachel S.² (AUTHOR) chella.vanderpost@radboudumc.nl, Nijkamp, Maarten W.¹ (AUTHOR), de Reuver, Philip R.³ (AUTHOR) philip.dereuver@radboudumc.nl, Fehrmann, Rudolf S. N.⁴ (AUTHOR) r.s.n.fehrmann@umcg.nl, Hoogwater, Frederik J. H.¹ (AUTHOR) h.kuipers01@umcg.nl

Source: Cancers. Nov2021, Vol. 13 Issue 21, p5257. 1p.

Subject Terms: *THERAPEUTIC use of monoclonal antibodies, *ONLINE information services, *GALLBLADDER tumors, *GENETIC mutation, *MOLECULAR diagnosis, *MEDICAL information storage & retrieval systems, *INFORMATION storage & retrieval systems, *MEDICAL databases, *CLINICAL trials, *SYSTEMATIC reviews, *GENETIC variation, *MEDLINE

Quality Assessment of Gallbladder Cancer Pathology Reports: A Dutch Nationwide Study.

Authors: de Bitter, Tessa J. J.¹ (AUTHOR) Tessa.JJ.deBitter@radboudumc.nl, de Savornin-Lohman, Elise A. J.² (AUTHOR) Elise.deSavorninLohman@radboudumc.nl, de Reuver, Philip R.² (AUTHOR) Philip.deReuver@radboudumc.nl, Versteeg, Valerie Sophie¹ (AUTHOR) Elisa.Vink-Borger@radboudumc.nl, Vink-Börger, Elisa¹ (AUTHOR) Iris.Nagtegaal@radboudumc.nl, Verheij, Joanne³ (AUTHOR) j.verheij@amsterdamumc.nl, Nagtegaal, Iris D.¹ (AUTHOR) Chella.vanderPost@radboudumc.nl, van der Post, Rachel S.¹ (AUTHOR)

Source: Cancers. Jun2021, Vol. 13 Issue 12, p2977. 1p.

Subject Terms: *GALLBLADDER tumors, *PATHOLOGY, *RETROSPECTIVE studies, *MEDICAL protocols, *QUALITY assurance

Geographic Terms: NETHERLANDS